BIAF Stock Analysis: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$0.60
-0.03 (-4.78%)
▼
5d:
-12.37%
30d:
-28.02%
90d:
-72.72%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIAF is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIAF is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $0.60, which is considered oversold relative to its 30-day fair value range of $0.65 to $0.80.
Technical Outlook: Technically, BIAF is in a strong downtrend. Immediate support is located at $0.56, while resistance sits at $0.72. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+904.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIAF is in a strong downtrend. Immediate support is located at $0.56, while resistance sits at $0.72. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+904.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.65 -
$0.80
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 904.4% below Wall St target ($6.00)
- WARNING: Recommendation downgraded due to -12.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.65 -
$0.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.56
Resistance Level
$0.72
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.07
Wall Street Target
$6.00
(+904.4%)
Revenue Growth (YoY)
-27.1%
Profit Margin
-280.6%
Share & Embed Analysis
Last updated: August 04, 2026 7:52 AM ET
Data refreshes hourly during market hours. Next update: 8:52 AM
Data refreshes hourly during market hours. Next update: 8:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 57 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 57 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 54 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 56 HOLD |
